Furthermore, our analysis with a database deposited in the public domain showed that CD52 mRNA expression in samples from patients with FLT3-ITD-positive AML tended to be higher than that in samples from patients with FLT3-ITD-negative AML (Supplemental Fig. S5). Here, FLT3 is linked to acute myeloid leukemia.